Bafna Pharmaceuticals Limited has informed the Exchange regarding 'Intimation for MPS Compliance'.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has submitted an intimation to the Exchange regarding its compliance with the Minimum Public Shareholding (MPS) requirement. This is a routine regulatory disclosure mandated for all listed companies, which must maintain at least 25% public shareholding as per SEBI norms. The company has informed the exchange about the status of this compliance. No specific details on the exact public shareholding percentage or any shortfall were provided in the headline.
This is a routine compliance update with no direct impact on shareholders or stock price. However, if the company were found non-compliant, it could face trading restrictions or penalties from the exchange. Investors should check the full filing for any specifics on shareholding percentage or remedial actions, if mentioned.